HIGHLIGHTS
- who: Zhizhong Shang from the Institute of Health Economics SRs/MAs have published the research: A systematic review, umbrella review, and quality assessment on clinical translation of stem cell therapy for knee osteoarthritis: Are we there yet?, in the Journal: (JOURNAL) of August/25,/2022
- what: The studies had poor quality evidence for six items related to the study objective, design, and population. Although 96% of the studies described the type, source, and transplantation dose of stem_cells, many patients received co-treatments such as arthroscopic debridement, microfracture, and high tibial osteotomy.
- how: Given . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.